Iranian Red Crescent Medical Journal

Published by: Kowsar

Effect of Nasal Calcitonin on the Health-Related Quality of Life in Postmenopause Women Affected With Low Bone Density

Majid Shohrati 1 , Noushin Bayat 2 , * , Amin Saburi 3 and Zahra Abbasi 4
Authors Information
1 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Internal Diseases Department, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Radiology Department, Birjand Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
4 Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: July 01, 2015, 17 (7); e6613
  • Published Online: July 31, 2015
  • Article Type: Research Article
  • Received: June 1, 2012
  • Revised: December 5, 2014
  • Accepted: March 6, 2015
  • DOI: 10.5812/ircmj.17(5)2015.6613

To Cite: Shohrati M, Bayat N, Saburi A, Abbasi Z. Effect of Nasal Calcitonin on the Health-Related Quality of Life in Postmenopause Women Affected With Low Bone Density, Iran Red Crescent Med J. 2015 ; 17(7):e6613. doi: 10.5812/ircmj.17(5)2015.6613.

Abstract
Copyright © 2015, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999; 10(4): 259-64[PubMed]
  • 2. Ofluoglu D, Karadag-Saygi E, Canbulat C, Gunduz OH, Kul-Panza E, Akyuz G. Early effect of nasal salmon calcitonin on the bone marker Crosslaps. Rheumatol Int. 2006; 26(4): 288-91[DOI][PubMed]
  • 3. Hallberg I, Rosenqvist AM, Kartous L, Lofman O, Wahlstrom O, Toss G. Health-related quality of life after osteoporotic fractures. Osteoporos Int. 2004; 15(10): 834-41[DOI][PubMed]
  • 4. Weiss M, Ben-Shlomo AB, Hagag P, Rapoport M. Reference database for bone speed of sound measurement by a novel quantitative multi-site ultrasound device. Osteoporos Int. 2000; 11(8): 688-96[DOI][PubMed]
  • 5. Chesnut CH, Silverman S, Andriano K, Genant H, Gimona A, Harris S, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. The American Journal of Medicine. 2000; 109(4): 267-76
  • 6. Huusko TM, Karppi P, Kautiainen H, Suominen H, Avikainen V, Sulkava R. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture. Calcif Tissue Int. 2002; 71(6): 478-84[PubMed]
  • 7. Trovas GP, Lyritis GP, Galanos A, Raptou P, Constantelou E. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers. J of Bone and Mineral Res. 2002; 17(3): 521-7
  • 8. Ellerington MC, Hillard TC, Whitcroft SI, Marsh MS, Lees B, Banks LM, et al. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int. 1996; 59(1): 6-11[PubMed]
  • 9. Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, et al. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Clin Rheumatol. 2005; 24(3): 232-8[DOI][PubMed]
  • 10. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005; 14(3): 875-82[PubMed]
  • 11. Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A. Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J. 2005; 11(3): 349-57[PubMed]
  • 12. Ali-Mohammadpour R, Yousefi Z. Factor analysis of SF-36 Persian version health-related quality of life questionnaire in Iran. World Applied Sciences Journal. 2008; 3(4): 548-54
  • 13. Persson LO, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol. 1998; 51(11): 1095-103[PubMed]
  • 14. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998; 51(11): 1105-13[PubMed]
  • 15. Sullivan M, Karlsson J, Ware JE. The Swedish SF-36 Health Survey—I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Social Science & Medicine. 1995; 41(10): 1349-58
  • 16. Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of C. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002; 167(10 Suppl)-34[PubMed]
  • 17. Sanchez-Riera L, Wilson N, Kamalaraj N, Nolla JM, Kok C, Li Y, et al. Osteoporosis and fragility fractures. Best Pract Res Clin Rheumatol. 2010; 24(6): 793-810[DOI][PubMed]
  • 18. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009; 301(5): 513-21[DOI][PubMed]
  • 19. Dennison EM, Jameson KA, Syddall HE, Martin HJ, Cushnaghan J, Aihie Sayer A, et al. Bone health and deterioration in quality of life among participants from the Hertfordshire cohort study. Osteoporos Int. 2010; 21(11): 1817-24[DOI][PubMed]
  • 20. Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, Kataxaki E, Papaioannou N, et al. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain. 1999; 15(4): 284-9[PubMed]
  • 21. Ofluoglu D, Akyuz G, Unay O, Kayhan O. The effect of calcitonin on beta-endorphin levels in postmenopausal osteoporotic patients with back pain. Clin Rheumatol. 2007; 26(1): 44-9[DOI][PubMed]
  • 22. Delmas PD. Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs. Osteoporosis international. 2000; 11(18)-76
  • 23. Yoshimura N, Kinoshita H, Takijiri T, Oka H, Muraki S, Mabuchi A, et al. Association between height loss and bone loss, cumulative incidence of vertebral fractures and future quality of life: the Miyama study. Osteoporosis International. 2008; 19(1): 21-8
  • 24. Romagnoli E, Carnevale V, Nofroni I, D’Erasmo E, Paglia F, De Geronimo S, et al. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporosis international. 2004; 15(12): 975-80
  • 25. Bolton KL, Egerton T, Wark J, Wee E, Matthews B, Kelly A, et al. Effects of exercise on bone density and falls risk factors in post-menopausal women with osteopenia: a randomised controlled trial. J Sci Med Sport. 2012; 15(2): 102-9[DOI][PubMed]
  • 26. Mehta NM, Malootian A, Gilligan JP. Calcitonin for osteoporosis and bone pain. Curr Pharm Des. 2003; 9(32): 2659-76[PubMed]
  • 27. Gennari C, Agnusdei D, Camporeale A. Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int. 1991; 49 Suppl 2-13[PubMed]
  • 28. Gemalmaz A, Discigil G, Sensoy N, Basak O. Identifying osteoporosis in a primary care setting with quantitative ultrasound: relationship to anthropometric and lifestyle factors. J Bone Miner Metab. 2007; 25(3): 184-92[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments